Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
about
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activatorAlpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon modelComplex formation of platelet thrombospondin with histidine-rich glycoproteinBIOLOGICAL ACTIVITIES OF C1 INHIBITORBinding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulinKinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrinComparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke.Binding of Lys-plasminogen to monocytes/macrophages.Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activityContribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptorSubstrates of Factor XIII-A: roles in thrombosis and wound healing.Microcirculatory aspects of venous ulceration.C1-inhibitor and its genetic alterations in hereditary angioneurotic edema.Lipoprotein(a) enhances plasma clot lysis in vitro.Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.Enzyme-linked immunosorbent assay (ELISA) for the measurement of small quantities of alpha 2-macroglobulin.Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
P2860
Q24301570-01B78980-9BFF-42A9-8381-7E439BDC8566Q24656054-AE22FD0A-3578-4706-A3A3-9151BBCC49D6Q28272068-00D47039-50BD-449D-A6F0-B185254D74AEQ28972362-EC61AF7A-8D11-46B6-A1A7-A5C4937714B8Q30444830-70A1890B-BF58-4684-A595-E8CBAB372D22Q30458129-D4EE4A25-3A32-423A-A9ED-B53947CDC45BQ33859197-7047290B-A089-422E-A982-56EAD13A5959Q35555017-EA79DD65-0C47-4DB0-A003-F67076B38CB1Q35594485-683026A7-1404-4003-BB93-75C5044C67A8Q36993272-B384CC34-9251-4AA6-B827-91BA11E65452Q37007907-07FDEC47-3EC7-4622-BE73-3845AD6A1DDBQ37016303-E35DC63E-1AE1-4B64-8AC3-3799AD19176FQ37271062-564ED018-96E3-45A9-8430-004770336848Q37374146-3C20D0D9-31A4-4A80-B7ED-5BAC85EDCD89Q38052936-9F36C7CD-10F0-4275-BFEB-13783C33C942Q40674098-8E91CC1C-BA0B-4AF9-965C-35C2242106CFQ40829855-F4C5DB7A-D74D-47AA-8268-1F25A1189CEBQ41197625-08F3BF09-4125-425F-A5A0-4AA436A45B7BQ42848184-F40133BB-AA0C-4D73-B05A-486AC8DC758DQ43885580-4D2772A3-06D9-4C84-8F28-26A0A9E88FFFQ51232674-C055AFF3-B030-4C93-993B-F41FE5FBDD1C
P2860
Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Alpha2-plasmin inhibitor and a ...... antibody immunosorbent assay.
@en
type
label
Alpha2-plasmin inhibitor and a ...... antibody immunosorbent assay.
@en
prefLabel
Alpha2-plasmin inhibitor and a ...... antibody immunosorbent assay.
@en
P2860
P356
P1476
Alpha2-plasmin inhibitor and a ...... antibody immunosorbent assay.
@en
P2093
P C Harpel
P2860
P356
10.1172/JCI110253
P407
P577
1981-07-01T00:00:00Z